U.S. Stock News

Recent commentary around UP Fintech Holding (NasdaqGS:TIGR) focuses on its operational momentum, cash position above US$500 million, and modest trailing P/E as investors weigh the impact of its pivot toward international brokerage markets. See our latest analysis for UP Fintech Holding. At a share price of US$8.15, UP Fintech’s short term share price return has been weak, with a 30 day share price decline of 18.42% and a year to date share price decline of 21.93%, while its 1 year total...

Ingles Markets (IMKT.A) has opened Q1 2026 with total revenue of US$1.4 billion and basic EPS of US$1.48, with trailing twelve month EPS at US$5.01 on revenue of US$5.4 billion, setting a clear earnings benchmark for investors watching its recent rebound in profitability. The company has seen quarterly revenue move from US$1.29 billion and EPS of US$0.87 in Q1 2025 to US$1.37 billion and EPS of US$1.48 in Q1 2026, while trailing margins have edged higher, giving this update a more...

CF Bankshares (CFBK) has rounded out FY 2025 with fourth quarter total revenue of US$14.6 million and basic EPS of US$0.89, supported by trailing twelve month revenue of US$52.7 million and EPS of US$2.70 against a current share price of US$33.31. Over the past few reporting periods, the company has seen quarterly revenue move from US$12.6 million in Q4 2024 to US$13.5 million in Q1 2025, US$14.2 million in Q2 2025, US$10.4 million in Q3 2025, and US$14.6 million in Q4 2025. Basic EPS has...

COPT Defense Properties (CDP) has put up another steady set of numbers, with Q3 FY 2025 revenue of US$190.6 million and basic EPS of US$0.37, alongside funds from operations of US$80.0 million that remain central to how many investors look at this REIT. The company has seen revenue move from US$183.7 million in Q4 2024 to US$190.3 million in Q2 2025 and US$190.6 million in Q3 2025, while basic EPS has ranged between US$0.31 and US$0.37 over the same stretch, giving you a clear read on how...

Earlier this week, Jazz Pharmaceuticals reported practice-changing results from its HERIZON-GEA trial and outlined plans to submit a supplemental Biologics License Application in the first half of 2026 for first-line gastroesophageal adenocarcinoma treatment as both doublet and triplet therapy with priority review. An important angle for investors is the expectation that these data could support broad first-line use and potential guideline inclusion across overlapping gastrointestinal cancer...

Piper Sandler Companies (PIPR) has put up another solid quarter, with Q3 FY 2025 revenue of US$479.3 million and basic EPS of US$3.61, supported by trailing twelve month EPS of US$14.36 on revenue of US$1.7 billion. Over the past year, the firm has seen total revenue move from US$1.4 billion on trailing EPS of US$8.64 at Q2 2024 to US$1.7 billion on EPS of US$14.36 at Q3 2025, alongside one year earnings growth of 44.1%. With net profit margins improving to 13.8% from 10.8% over the last 12...

Sun Country Airlines Holdings (SNCY) just wrapped up FY 2025 with Q4 revenue of US$281 million and basic EPS of US$0.15, alongside trailing twelve month revenue of US$1.13 billion and EPS of US$0.99 that frame the full year picture. Over the past year, the company has seen revenue move from US$1.08 billion and EPS of US$1.00 on a trailing basis in Q4 FY 2024 to US$1.13 billion and EPS of US$0.99 in Q4 FY 2025, giving investors a clear line of sight on how the top line and per share earnings...

If you are trying to work out whether Atmus Filtration Technologies is still good value after its recent run, this article will walk through what the current price might be implying. The stock last closed at US$61.46, with returns of 6.0% over 7 days, 16.5% over 30 days, 17.3% year to date, and 50.8% over the past year. This raises questions about how much future upside or risk is already reflected in the price. Recent coverage of Atmus has focused on its position as a specialist filtration...

MDU Resources Group (MDU) just wrapped up FY 2025 with fourth quarter revenue of US$534 million and basic EPS of US$0.37, while trailing twelve month EPS came in at US$0.94 on revenue of about US$1.9 billion. Over recent quarters, the company has seen quarterly revenue range from US$315 million to US$675 million, with basic EPS moving between US$0.07 and US$0.40, giving investors a clear view of how earnings track through different parts of the year. With net margin sitting close to flat...

Pathward Financial (CASH) just posted its Q1 2026 scorecard, with total revenue at US$169.9 million and basic EPS of US$1.57 setting the tone for how the quarter landed. Over recent periods, the company has seen quarterly revenue move from US$169.9 million in Q4 2024 to US$163.97 million in Q1 2025, and then to US$169.9 million in Q1 2026. Basic EPS has shifted from US$1.34 to US$1.23 and now US$1.57, giving investors a clear line of sight on how the top and bottom lines are tracking into...

EastGroup Properties (EGP) has capped FY 2025 with fourth quarter total revenue of US$189.2 million and basic EPS of US$1.27, alongside funds from operations of US$124.8 million, giving investors a clean snapshot of how the industrial REIT is currently performing. The company has seen total revenue move from US$164.0 million in Q4 2024 to US$189.2 million in Q4 2025, while basic EPS shifted from US$1.17 to US$1.27 over the same period. This frames a year where the income statement and cash...

Newell Brands (NWL) has put up mixed numbers for FY 2025 so far, with Q3 revenue of US$1.8 billion, basic EPS of US$0.05 and net income, excluding extra items, of US$21 million. Over recent quarters the company has seen revenue move from US$2.0 billion in Q2 2024 to US$1.6 billion in Q1 2025 and then to US$1.8 billion in Q3 2025. Basic EPS has ranged from a loss of US$0.48 in Q3 2024 to a profit of US$0.11 in Q2 2025 and US$0.05 in Q3 2025. That kind of choppy path keeps the focus squarely on...

IREN (IREN) has just put fresh numbers on the table for Q2 2026, with the latest quarter showing total revenue of US$240.3 million and basic EPS of US$1.42, while trailing twelve month revenue sits at US$688.6 million and EPS at US$2.23. Over recent quarters the company has seen revenue move from US$52.8 million and an EPS loss of US$0.27 in Q1 2025, to US$117.9 million and EPS of US$0.09 in Q2 2025, then to US$148.1 million and EPS of US$0.11 in Q3 2025, and further to US$180.6 million with...

LiveRamp Holdings (RAMP) just posted Q3 2026 results with revenue of US$212.2 million and basic EPS of US$0.63, set against a trailing twelve month picture of US$795.6 million in revenue and EPS of US$1.06. Over recent quarters, the company has seen revenue move from US$185.5 million in Q2 2025 to US$212.2 million in Q3 2026, while quarterly basic EPS shifted from US$0.03 to US$0.63, giving investors a clearer view of how the income statement is scaling. With the business now reporting...

Financial results set the stage for Spectrum Brands Holdings' latest earnings story Spectrum Brands Holdings (SPB) opened Q1 2026 with revenue of US$677 million and basic EPS of US$1.26. This sets a straightforward benchmark for investors weighing the new numbers against the current share price of US$75.72. The company reported quarterly revenue of US$700.2 million and EPS of US$0.87 in Q1 2025, compared with revenue of US$677 million and EPS of US$1.26 in Q1 2026. Over the trailing twelve...

Symbotic Q1 2026 earnings in focus Symbotic (SYM) has opened fiscal 2026 with Q1 revenue of US$630.0 million and Basic EPS of US$0.02, setting the tone for how investors assess its path toward sustained profitability. The company has seen revenue rise from US$486.7 million in Q1 2025 to US$630.0 million in Q1 2026, while Basic EPS has shifted from a loss of US$0.03 to a profit of US$0.02 over the same period, giving this quarter a clearer view of how margins are shaping up. See our full...

Virtus Investment Partners (NYSE:VRTS) is expanding into private markets through a majority stake in Keystone National Group and a minority investment in Crescent Cove. The firm is also launching new actively managed ETFs as it adjusts its product lineup alongside recent equity outflows. These moves reshape Virtus Investment Partners' business mix beyond its traditional equity focused strategies. For investors watching NYSE:VRTS, the timing of these steps comes after a period of weaker...

CC Pharma, Tilray Brands' European pharmaceutical distribution arm, was named a TOP 100 Innovator in Germany, highlighting its role in medical cannabis and broader pharma distribution. Breckenridge Distillery, a Tilray Brands spirits label, expanded its distribution through a new partnership in Illinois, increasing its presence in the U.S. market. For investors watching NasdaqGS:TLRY, these updates relate to two of the company’s key business lines: medical cannabis in Europe and branded...

Why WesBanco’s latest earnings moved the stock WesBanco (WSBC) shares reacted after fourth quarter results met revenue expectations but modestly missed non GAAP earnings, as management discussed acquisition integration, deposit trends, expense actions, and growth plans in newer markets. See our latest analysis for WesBanco. The share price reaction around earnings sits within a stronger recent trend, with a 7 day share price return of 6.02% and a 90 day share price return of 20.87%, while the...

If you are trying to work out whether Iovance Biotherapeutics is a bargain or a value trap at its current share price, you will want a clear view of what the market is actually paying for its future prospects. The stock last closed at US$2.36 and has posted returns of a 10.3% decline over 7 days, 7.5% decline over 30 days, 6.3% decline year to date, 59.9% decline over 1 year, 68.2% decline over 3 years and 95.1% decline over 5 years, which will influence how investors think about its risk...

If you are wondering whether AllianceBernstein Holding is fairly priced or offering value at its current level, this article walks through the key signals that matter for long term investors. The stock last closed at US$42.36, with reported returns of 2.6% over 7 days, 7.0% over 30 days, 9.6% year to date, 28.4% over 1 year, 36.5% over 3 years and 66.0% over 5 years, which gives useful context before assessing what you are paying for today. Recent share price moves have been covered...

StoneX Group’s Q1 2026 earnings put recent growth in focus StoneX Group (SNEX) opened its new fiscal year with Q1 2026 revenue of about US$38.5b and basic EPS of US$2.75, setting the tone after a year where earnings were reported to have grown 30.7%. The company has seen quarterly revenue move from US$27.6b in Q1 2025 to US$38.5b in Q1 2026, while basic EPS over that stretch ranged from US$1.29 to US$2.75, alongside trailing twelve month EPS of US$7.21 backed by net income of US$349.4m. With...

If you are wondering whether Ardent Health's current share price reflects its real worth, this article will walk you through what the numbers are saying about value. The stock last closed at US$8.58, with a 4.1% return over the past 7 days, a 7.9% decline over the last 30 days, and a 0.7% decline year to date, compared with a 42.3% decline over the past year. Recent news flow around Ardent Health has largely centered on its position within the US healthcare sector and how investors are...

In early February 2026, GLJ Research downgraded Daqo New Energy from Buy to Sell, citing concerns over China’s polysilicon supply-demand balance and uneven policy execution intended to curb excess capacity. The firm also projected that Daqo’s net losses could narrow in 2025 compared with 2024, highlighting operational improvement that contrasts with persistent industry headwinds. We’ll now examine how GLJ Research’s downgrade, driven by China’s polysilicon market uncertainties, shapes Daqo...